These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7917554)

  • 1. Determination of oestrogen receptors by enzyme immunoassay.
    Weigand RA; Lynch D; Cotter D
    Eur J Cancer; 1994; 30A(6):888. PubMed ID: 7917554
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences.
    Romain S; Formento JL; Guirou O; Francoual M; Milano G; Martin PM
    Eur J Cancer; 1994; 30A(6):740-6. PubMed ID: 7917530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of oestrogen receptor by enzyme immunoassay.
    Hyder SM
    Eur J Cancer; 1995; 31A(5):852-3. PubMed ID: 7640084
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
    Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
    Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
    [No Abstract]   [Full Text] [Related]  

  • 5. [Calibration and standardization in enzyme immunoassay].
    Kuwa K
    Nihon Rinsho; 1995 Sep; 53(9):2232-8. PubMed ID: 7474386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interlaboratory comparison of oestrogen receptor data.
    Thorpe SM
    Eur J Cancer; 1994; 30A(6):730-2. PubMed ID: 7917528
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of the presence of progesterone receptors on the relationship between enzyme immunoassay and steroid-binding assay for oestrogen receptors.
    Marsigliante S; Puddefoot J; Vinson GP; Gilmore OJ
    Biochem Soc Trans; 1990 Aug; 18(4):565-6. PubMed ID: 2276439
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of oestrogen receptors: application of the Passing-Bablock linear regression technique for comparison of enzyme immunoassay and radioligand binding assay in 1841 breast cancer tumours.
    Romain S; Dussert C; Martin PM
    Eur J Cancer; 1991; 27(6):715-20. PubMed ID: 1829910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay.
    Dittadi R; Meo S; Amoroso B; Gion M
    Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lability of estrogen receptor: correlation of estrogen binding and immunoreactivity.
    Clayton F; Wu J
    Clin Chem; 1986 Sep; 32(9):1774-7. PubMed ID: 3527482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunospecificity differences between Roche fluorescence polarization immunoassay and Syva EMIT assay of quinidine.
    Malikin G; Lam S
    Clin Chem; 1992 Apr; 38(4):603-5. PubMed ID: 1568340
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems related to determination of reference interval and clinical decision limit in enzyme immunoassay].
    Ichihara K
    Nihon Rinsho; 1995 Sep; 53(9):2220-30. PubMed ID: 7474385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
    Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M
    J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
    Romain S; Lainé Bidron C; Martin PM; Magdelenat H
    Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of the national reference panel for hepatitis B surface antigen].
    Wu X; Zhou C; Gu WJ; Li HM; Qi ZB
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):311-3. PubMed ID: 19105354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of dextran coated charcoal (DCC) and enzyme immunoassay (EIA) methods for oestrogen receptor (ER) estimation in breast cancer.
    Redkar AA; Kabre SS; Mittra I
    Indian J Cancer; 1991 Mar; 28(1):9-15. PubMed ID: 1769684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods.
    Aasmundstad TA; Haugen OA; Johannesen E; Høe AL; Kvinnsland S
    J Clin Pathol; 1992 Feb; 45(2):125-9. PubMed ID: 1371776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-‑quality manufactured immunoenzymatic assay kits as a source of confusion in science.
    Chudek J; Bożentowicz-Wikarek M
    Pol Arch Intern Med; 2017 Apr; 127(4):287-288. PubMed ID: 28430169
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of breast.
    Leung SW; Bédard YC
    Am J Clin Pathol; 1999 Jul; 112(1):50-6. PubMed ID: 10396285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of the evaluation reference system for domestic anti-hepatitis C virus diagnostic enzyme immunoassay kits].
    Niu X; Wang X; Liu G; Li Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):761-4. PubMed ID: 23837990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.